{"DataElement":{"publicId":"2630250","version":"1","preferredName":"Cytogenetic Analysis BCR-ABL Oncoprotein Cell Assessment Ratio Upper Limit of Normal Value","preferredDefinition":"the upper limit of normal of the International Normalization Ratio value as related for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities by an onco-protein generated from the fusion of Bcr and Abl genes by translocation process between chromosome 9 and 22 (Philadelphia chromosome), in CML (P210) and some ALL (P190).","longName":"CA_BCRABL_CA_RULN_VA","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2630231","version":"1","preferredName":"Cytogenetic Analysis BCR-ABL Oncoprotein Cell Assessment","preferredDefinition":"information related to techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities by an onco-protein generated from the fusion of Bcr and Abl genes by translocation process between chromosome 9 and 22 (Philadelphia chromosome), in CML (P210) and some ALL (P190).","longName":"CTYOAN_BCRABL_C_ASS","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2626353","version":"1","preferredName":"Cytogenetic Analysis","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","longName":"C18280","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DFFACB0-002E-03CB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-04-13","modifiedBy":"ONEDATA","dateModified":"2007-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2630229","version":"1","preferredName":"BCR-ABL Oncoprotein Cell Assessment","preferredDefinition":"An onco-protein generated from the fusion of Bcr and Abl genes by translocation process between chromosome 9 and 22 (Philadelphia chromosome), in CML (P210) and some ALL (P190).:The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.:Examination of the body by auscultation, palpation, percussion, inspection, and olfaction.  (Taber's)","longName":"C16325:C12508:C20989","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Protein","conceptCode":"C16325","definition":"A fusion protein encoded by the BCR/ABL1 fusion gene. This protein is comprised of the N-terminus of the breakpoint cluster region protein fused to almost the entire tyrosine-protein kinase ABL1 protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E8C82A8-42A5-34C9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-04-20","modifiedBy":"ONEDATA","dateModified":"2007-04-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E8C82A8-42B6-34C9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-04-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2190393","version":"1","preferredName":"International Normalization Ratio Lab Upper Limit of Normal Value","preferredDefinition":"the upper limit of normal of the International Normalization Ratio value.","longName":"INR_LAB_ULN_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2500946","version":"1","preferredName":"Upper Limit of Normal Value","preferredDefinition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.:A numerical quantity measured or assigned or computed.","longName":"C25706:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper Limit of Normal","conceptCode":"C25706","definition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19E48A60-907F-415C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-07-31","modifiedBy":"ONEDATA","dateModified":"2006-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E79AD8B0-CB0F-1A5F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-29","modifiedBy":"CAMPBELB","dateModified":"2009-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2670694","version":"1","longName":"Disease Relapse","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2812924","version":"1","longName":"Chronic Myelogenous Leukemia Relapse","context":"NHLBI"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"BCR-ABL/ABL ratio ULN","type":"Preferred Question Text","description":"BCR-ABL/ABL ratio ULN","url":null,"context":"NHLBI"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E8F5460-6180-5AB7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-04-20","modifiedBy":"KUMMEROA","dateModified":"2021-08-23","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}